BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33052601)

  • 1. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma.
    Palacios-Ferrer JL; García-Ortega MB; Gallardo-Gómez M; García MÁ; Díaz C; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias-Santiago S; Amezcua V; Peinado H; Vicente F; Pérez Del Palacio J; Marchal JA
    Mol Oncol; 2021 Feb; 15(2):407-428. PubMed ID: 33052601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma.
    García-Ortega MB; Aparicio E; Griñán-Lisón C; Jiménez G; López-Ruiz E; Palacios JL; Ruiz-Alcalá G; Alba C; Martínez A; Boulaiz H; Perán M; Hackenberg M; Bragança J; Calado SM; Marchal JA; García MÁ
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of STAT3 targets a subpopulation of invasive melanoma stem-like cells.
    Kulesza DW; Przanowski P; Kaminska B
    Cell Biol Int; 2019 Jun; 43(6):613-622. PubMed ID: 30958597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of exosomes in metastasis and progression of melanoma.
    Gowda R; Robertson BM; Iyer S; Barry J; Dinavahi SS; Robertson GP
    Cancer Treat Rev; 2020 Apr; 85():101975. PubMed ID: 32050108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiles of melanoma cell-derived exosomes in plasma: discovery of potential biomarkers of melanoma progression.
    Mondal SK; Whiteside TL
    Melanoma Res; 2021 Oct; 31(5):472-475. PubMed ID: 34284459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules.
    Surman M; Kędracka-Krok S; Hoja-Łukowicz D; Jankowska U; Drożdż A; Stępień EŁ; Przybyło M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
    Brinckerhoff CE
    J Cell Physiol; 2017 Oct; 232(10):2674-2678. PubMed ID: 28078710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells in melanoma development.
    Sabatino M; Stroncek DF; Klein H; Marincola FM; Wang E
    Cancer Lett; 2009 Jul; 279(2):119-25. PubMed ID: 19095348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
    Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
    Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
    Malla R; Puvalachetty K; Vempati RK; Marni R; Merchant N; Nagaraju GP
    Clin Breast Cancer; 2022 Aug; 22(6):507-514. PubMed ID: 35688785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing cancer stem cell-derived exosomes to improve cancer therapy.
    Yang J; Teng Y
    J Exp Clin Cancer Res; 2023 May; 42(1):131. PubMed ID: 37217932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma.
    Alia Moosavian S; Hashemi M; Etemad L; Daneshmand S; Salmasi Z
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109320. PubMed ID: 36274482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
    Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA
    Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAB27A-dependent release of exosomes by liver cancer stem cells induces Nanog expression in their differentiated progenies and confers regorafenib resistance.
    Huang H; Hou J; Liu K; Liu Q; Shen L; Liu B; Lu Q; Zhang N; Che L; Li J; Jiang S; Wang B; Wen Q; Hu L; Gao J
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3429-3437. PubMed ID: 34258777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance.
    Hoque S; Dhar R; Kar R; Mukherjee S; Mukherjee D; Mukerjee N; Nag S; Tomar N; Mallik S
    Biomarkers; 2023 Mar; 28(2):139-151. PubMed ID: 36503350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.
    Xiao D; Barry S; Kmetz D; Egger M; Pan J; Rai SN; Qu J; McMasters KM; Hao H
    Cancer Lett; 2016 Jul; 376(2):318-27. PubMed ID: 27063098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.